FDA Inspection 1135087 — Novacyl (Thailand) Ltd.

Novacyl (Thailand) Ltd. — FEI 3000287096

The FDA completed an inspection of Novacyl (Thailand) Ltd. on March 14, 2019 in Mueang Samut Prakan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 14, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mueang Samut Prakan (Thailand)

Additional Details

Mutual Recognition Agreement (MRA)